About this medicine

Its bipolar benefit is preventive; the UK licence does not cover treating an acute manic or depressive episode.

What is this medicine used for?

The psychiatric licence is for adults with bipolar I disorder dominated by depressive episodes. NICE also discusses off-label treatment of bipolar depression. Epilepsy indications have different age limits.

Which warning signs need help?

Seek urgent medical assessment for a new rash, blistering, peeling skin, fever or mouth sores. Breathing difficulty or collapse is an emergency. Use local emergency services outside the UK.

Fever with swollen glands or organ symptoms can signal a serious immune reaction even before a rash appears. Severe headache with neck stiffness, new neurological symptoms, or suicidal thinking also requires urgent assessment.

How do I take it safely?

Without valproate or enzyme-inducing medicines, the adult bipolar schedule progresses from 25 mg/day for two weeks to 50 mg/day for two weeks, then 100 mg/day in week five and usually 200 mg/day in week six. Other combinations require different schedules. This describes the label, not instructions to change treatment.

Standard tablets are swallowed whole. Dispersible tablets may be dispersed, but do not take only part of the resulting mixture. Product form does not remove the need for slow escalation.

What side effects should I know about?

Common problems include headache, nausea, dizziness, tiredness and rash. A rash should not be dismissed as an ordinary nuisance.

Who needs extra care with this medicine?

Previous allergy, liver or kidney disease and heart conditions, including Brugada syndrome, need assessment.

Can it affect my other medicines?

Valproate, carbamazepine, rifampicin and hormonal contraception can affect treatment. Starting or stopping the combined pill needs a medication review.

Valproate slows lamotrigine clearance and increases rash risk if the wrong escalation schedule is used. Oestrogen-containing contraception can lower lamotrigine levels; levels may rise during a pill-free week or after stopping contraception. Discuss breakthrough bleeding and contraception changes promptly.

What check-ups will I need?

Before you start lamotrigine for bipolar disorder, NICE recommends blood tests to check your blood cells, kidneys, body salts and liver. Your care team will also ask about mood changes, rashes and other medicines.

What about pregnancy, breastfeeding and age?

Pregnancy planning needs specialist discussion. MHRA pregnancy evidence is comparatively reassuring for lamotrigine, but does not mean zero risk. Breastfed babies may need observation for rash, sleepiness or poor growth. Bipolar use below 18 is not recommended in the checked licence.

The SmPC recommends specialist pregnancy planning, folic acid supplementation, and concentration checks before, during and after pregnancy. Levels can fall during pregnancy and rise rapidly after birth; dose review protects against loss of seizure control or toxicity. Epilepsy use includes specified indications from age two, not a psychiatric licence at that age.

What if I miss a dose or want to stop?

Do not double a missed dose. After an interruption, seek advice about restarting slowly; returning directly to the former dose can increase rash risk.

How does it work?

Lamotrigine affects the channels that help nerve cells produce electrical signals. Laboratory studies suggest that it can limit repeated firing, meaning the sending of electrical signals, and influence the release of chemical messengers. These findings help explain some of its actions, although scientists have not established exactly how they produce its benefits in bipolar disorder.

How Brain Cells Communicate

A nerve cell, or neuron, carries a brief electrical signal along its long connecting branch, called an axon. The signal depends on charged particles called ions moving through channels in the cell’s outer membrane. When it reaches a nerve ending, it can trigger the release of a neurotransmitter: a chemical messenger that travels across a tiny gap to another cell.

What is known: Electrical signals and chemical messengers are linked stages of communication between nerve cells.

What remains uncertain: A single electrical signal does not explain a person’s mood or a seizure.

Complete multipolar neuron with dendritic branches, a cell body and nucleus, one myelinated axon, nodes between myelin segments, and branching nerve terminals. Receiving branches: Dendrites connect with signals arriving from other cells. Cell body: The cell body joins the receiving branches to the axon. Axon: Changing voltage propagates along its membrane; no particle travels along the arrow. Nerve terminals: The signal can trigger release of chemical messengers. Myelin: Insulating coverings wrap sections of many axons; the gaps are called nodes of Ranvier.
  1. Receiving branches

    Dendrites connect with signals arriving from other cells.

  2. Cell body

    The cell body joins the receiving branches to the axon.

  3. Axon

    Changing voltage propagates along its membrane; no particle travels along the arrow.

  4. Nerve terminals

    The signal can trigger release of chemical messengers.

  5. Myelin

    Insulating coverings wrap sections of many axons; the gaps are called nodes of Ranvier.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Electrical signals and chemical messengers are linked stages of communication between nerve cells. Simplified illustration of the process; individual responses vary.
About this illustration

Receiving branches lead to a cell body and a long axon ending at a nerve terminal. A single electrical signal does not explain a person’s mood or a seizure.

How the Medication Changes Signaling

Sodium channels are proteins that allow sodium ions to enter a cell briefly; they then become temporarily unavailable and recover before helping produce another signal. In laboratory studies, lamotrigine interferes with these voltage-sensitive channels, meaning channels that respond to changes in electrical charge. Its effect depends partly on the channel’s current state, an action called state-dependent inhibition. This can make rapid, repeated firing harder to sustain and change the release of glutamate, a messenger that usually increases the receiving cell’s activity.

What is known: Experiments show effects on voltage-sensitive sodium channels and release of messengers that increase cell activity.

What remains uncertain: The importance of each cellular effect in humans has not been fully established.

Without medicine: ready

A voltage-sensitive sodium channel with a closed inner gate and ions outside above the membrane. Sodium · Na+: Sodium can enter through an available open channel. Voltage-sensitive sodium channel: Closed, open and inactivated are distinct channel states. Closed and ready: No flow arrow is shown through the closed pore.
  1. Sodium · Na+

    Sodium can enter through an available open channel.

  2. Voltage-sensitive sodium channel

    Closed, open and inactivated are distinct channel states.

  3. Closed and ready

    No flow arrow is shown through the closed pore.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Without medicine: open

An open voltage-sensitive sodium channel with ions passing inward from above to below the membrane. Sodium · Na+: Sodium can enter through an available open channel. Voltage-sensitive sodium channel: Closed, open and inactivated are distinct channel states. Open channel: The arrow shows a qualitative direction, not an ion count or measured rate.

Optional motion shows inward ion movement in this example. Counts and timing are illustrative.

  1. Sodium · Na+

    Sodium can enter through an available open channel.

  2. Voltage-sensitive sodium channel

    Closed, open and inactivated are distinct channel states.

  3. Open channel

    The arrow shows a qualitative direction, not an ion count or measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Without medicine: inactivated

A sodium-channel pore with a distinct tethered inner inactivation gate. It differs from the closed available state. Sodium · Na+: Sodium can enter through an available open channel. Voltage-sensitive sodium channel: Closed, open and inactivated are distinct channel states. Temporarily unavailable: The inactivation mark differs from the closed, available gate.
  1. Sodium · Na+

    Sodium can enter through an available open channel.

  2. Voltage-sensitive sodium channel

    Closed, open and inactivated are distinct channel states.

  3. Temporarily unavailable

    The inactivation mark differs from the closed, available gate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

With lamotrigine: laboratory effect

A sodium channel with reduced availability and a separate medicine symbol. No experimentally determined binding location is depicted. Sodium · Na+: Sodium can enter through an available open channel. Voltage-sensitive sodium channel: Closed, open and inactivated are distinct channel states. Lamotrigine: current reduced: The medicine symbol labels an action, not an experimentally determined binding position.
  1. Sodium · Na+

    Sodium can enter through an available open channel.

  2. Voltage-sensitive sodium channel

    Closed, open and inactivated are distinct channel states.

  3. Lamotrigine: current reduced

    The medicine symbol labels an action, not an experimentally determined binding position.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Experiments show effects on voltage-sensitive sodium channels and release of messengers that increase cell activity. Simplified illustration of the process; individual responses vary.
About this illustration

Three channel states: closed and ready, open with inward sodium flow, and inactivated. The importance of each cellular effect in humans has not been fully established.

A Closer Look at the Molecular Level

Scientists can investigate this action by measuring electrical currents in individual cells, including experiments on rat nerve cells. A reduction in sodium current can then be related to changes in how often the cell fires. A whole brain contains many connected cells and other signaling systems, so these experiments provide one part of the evidence used to understand the medicine.

What is known: The proposed sodium-channel action is supported by laboratory evidence.

What remains uncertain: The mechanism responsible for lamotrigine’s benefit in bipolar disorder remains unresolved.

What the experiment measures

From experiment to understanding

Electrical current

  • Electrical current The observation belongs to the stated experimental system.
  • Limits of inference An experimental result does not by itself predict one person’s treatment response.

What those studies suggest

From experiment to understanding

Reduced repetitive firing

  • Reduced repetitive firing The observation belongs to the stated experimental system.
  • Limits of inference An experimental result does not by itself predict one person’s treatment response.

What the studies do not establish

What this model cannot tell us

Bipolar mechanism unknown

  • Bipolar mechanism unknown The clinical explanation remains uncertain.
  • Limits of inference An experimental result does not by itself predict one person’s treatment response.
The proposed sodium-channel action is supported by laboratory evidence. Simplified illustration of the process; individual responses vary.
About this illustration

Three evidence levels: sodium currents reduced in cell experiments; repetitive firing may be reduced; the link to bipolar benefit remains unresolved. The mechanism responsible for lamotrigine’s benefit in bipolar disorder remains unresolved.

How does it affect my body?

Dizziness or sleepiness can affect driving. Headaches, nausea and sleep changes may occur.

How does my body process it?

Your liver uses a process called glucuronidation to change lamotrigine into substances your body can remove, mainly in urine. Other medicines can speed up or slow down this process, which can change lamotrigine levels.

How do treatment options differ?

It has a different role from treatments for acute mania: NICE advises against using it to treat mania.

A closer look at the science

Lamotrigine blocks voltage-gated sodium channels in an activity-dependent way and reduces glutamate release. These actions do not establish a complete explanation of its mood effects.

The drawing represents neutral lamotrigine, the active molecule, using the atom connections and two-dimensional coordinates in PubChem CID 3878. It is not a salt, tablet formulation or protein-bound model.

Chemical formula: C9H7Cl2N5

This means 9 carbon atoms, 7 hydrogen atoms, 2 chlorine atoms and 5 nitrogen atoms. Lines show bonds; double lines show double bonds. All atoms are labeled in this teaching drawing.

Two connected rings with carbon and nitrogen atoms, two chlorine atoms and two amino groups. Every atom is labeled; formula C9H7Cl2N5.
Original rendering of PubChem’s verified 2D connectivity and coordinates, CID 3878. Atom positions on this page are a drawing convention, not an experimental 3D pose.

How was this medicine developed?

The checked Lamictal record lists initial UK tablet authorisations in 1991.

Sources and References

  1. Lamictal tablets and chewable/dispersible tablets — UK SmPC

    Product covered: Lamictal tablets and chewable/dispersible tablets. Marketing authorisation holder: The Wellcome Foundation Ltd, trading as GlaxoSmithKline UK. Label text revised 2025-11-05; source record updated 2025-11-19. Product identity and links checked 2026-10-19; this does not change the article’s clinical check date.

    Company-supplied UK Patient Information Leaflet hosted by emc — patient text revised 2026-06. The opened PIL is for conventional tablets; do not silently apply it to chewable/dispersible products.

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom product information.

  2. Lamictal tablets and chewable/dispersible tablets — Company-supplied UK Patient Information Leaflet hosted by emc
  3. Lamotrigine

    Scope: NHS website medicines information (England); not a guarantee of identical services across UK nations.

  4. Lamictal tablets — patient leaflet

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom product information.

  5. Bipolar disorder: assessment and management (CG185), recommendations

    Scope: NICE guidance for England; application in other UK nations determined separately.

  6. Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review

    Scope: United Kingdom.

  7. Lamictal in-use labeling and patient guide — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: 12.1 Mechanism of Action..

  8. Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: Abstract: voltage-, use- and state-dependent inhibition in cell experiments..

  9. What Is a Neurotransmitter?
  10. Lamictal prescribing information and Medication Guide (revised October 2025)
  11. Sodium-channel states in rat nerve-cell experiments by Kuo and Lu
  12. Lamotrigine chemical record: PubChem CID 3878
  13. Verified two-dimensional atoms and bonds for lamotrigine

Shared scientific background. Some references are US product pharmacology or international chemical records; UK product details and prescribing information are verified separately.

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top